AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H951. A total of 5 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151 | +21.9% | 117,500 | +43.6% | 0.00% | +100.0% |
| Q2 2023 | $1,764 | +22.2% | 81,800 | +66.3% | 0.00% | 0.0% |
| Q1 2023 | $1,443 | -32.4% | 49,200 | -14.9% | 0.00% | -50.0% |
| Q4 2022 | $2,135 | -99.9% | 57,800 | -43.6% | 0.00% | -33.3% |
| Q3 2022 | $2,885,000 | +2596.3% | 102,500 | +1730.4% | 0.00% | – |
| Q2 2022 | $107,000 | +109.8% | 5,600 | +40.0% | 0.00% | – |
| Q1 2022 | $51,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 9,000 | $253,000 | 0.09% |
| GROUP ONE TRADING, L.P. | 275,600 | $7,758,000 | 0.02% |
| JANE STREET GROUP, LLC | 304,900 | $8,583,000 | 0.00% |
| SIMPLEX TRADING, LLC | 102,500 | $2,885,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |